Abstract
Aims of the symposium The permanent acquirement and clinical application of exponentially growing new scientific discoveries are demanding tasks for academic neurologists. To facilitate the overview of recent developments in basic and clinical sciences of inflammatory demyelination we invited seven internationally recognized experts in multiple sclerosis (MS) to discuss their most recent works. These lectures allowed the audience to formulate a modern concept of MS by integrating data from studies on molecular pathogenesis, genetics, MRI characteristics and clinical trials. The audience was invited from the broader medical community including graduate and medical students, neurology residents, private practitioners, academic neurologists, clinical and research specialists of MS.